A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease
Part of paid clinical trials in Birmingham, Alabama.
- Sponsor
- Hoffmann-La Roche
- Study ID
- NCT05595642
- Phase
- PHASE3
- Status
- Active Not Recruiting
Conditions
- Chronic Obstructive Pulmonary Disease (COPD)
Eligibility Criteria
- Sex
- ALL
- Age
- 40 Years - 80 Years
- Healthy Volunteers
- Not accepted
Interventions
- Astegolimab — DRUGParticipants will receive SC astegolimab Q2W or Q4W
- Placebo — DRUGParticipants will receive SC placebo Q2W
Study Details
This study will evaluate the efficacy and safety of astegolimab compared with placebo in participants with chronic obstructive pulmonary disease (COPD) who are former or current smokers and have a history of frequent exacerbations.
Key Dates
- Start date
- Dec 29, 2022
- Status verified
- May 2026
- Primary completion
- Jun 24, 2025
- Completion
- Sep 24, 2027
Study Design
- Enrollment
- 1,290 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Astegolimab SC Q2WParticipants will receive subcutaneous (SC) astegolimab every 2 weeks (Q2W)
- Experimental: Astegolimab SC Q4WParticipants will receive alternating SC astegolimab and placebo Q2W, thus receiving SC astegolimab Q4W.
- Placebo Comparator: Placebo SC Q2WParticipants will receive SC placebo Q2W
Primary Outcome Measure
Annualized rate of moderate and severe COPD exacerbations over the 52-week treatment period [ Time Frame: 52 weeks ]
Locations (53)
Find similar trials in Birmingham, AL
By research site
University of Alabama at Birmingham· Birmingham, ALSEC Clinical Research LLC - Dothan 2 - ClinEdge - PPDS· Dothan, ALPulmonary Associates PA· Glendale, AZAES - DRS - Synexus Clinical Research US, Inc. - Tucson· Tucson, AZKern Research· Bakersfield, CAAllergy & Asthma Medical Group of the Bay Area· Walnut Creek, CA
Related Studies
- Collection of Airway, Blood and/or Urine Specimens From Subjects for Research StudiesRecruiting · Weill Medical College of Cornell University · New York, New York
- Multi-Center Clean Air Randomized Controlled Trial in COPDPHASE3 · Recruiting · JHSPH Center for Clinical Trials · Birmingham, Alabama
- Quest to Analyze One Thousand Humans MeditatingEnrolling By Invitation · Tobias Moeller-Bertram · Palm Desert, California
- A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)PHASE3 · Recruiting · AstraZeneca · Cullman, Alabama